Additionally, increased the AR expression in RCC was reported to have repressed miR-143-3p, causing the loss of its regulatory effect on K-RAS, P-ERK, and AKT, the commonly activated pathways in cancer [99,100]. Here, AR is linked to renal cell carcinoma.